|
STARD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.972740E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.15469997399964E-09 |
| Normal-vs-Stage2 |
1.216840E-01 |
| Normal-vs-Stage3 |
3.568800E-01 |
| Normal-vs-Stage4 |
8.817000E-01 |
| Stage1-vs-Stage2 |
1.578980E-01 |
| Stage1-vs-Stage3 |
3.401900E-02 |
| Stage1-vs-Stage4 |
2.137400E-01 |
| Stage2-vs-Stage3 |
6.033200E-01 |
| Stage2-vs-Stage4 |
4.676800E-01 |
| Stage3-vs-Stage4 |
6.282600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.834410E-04 |
| Normal-vs-AfricanAmerican |
5.792200E-04 |
| Normal-vs-Asian |
7.600200E-01 |
| Caucasian-vs-AfricanAmerican |
8.888800E-01 |
| Caucasian-vs-Asian |
2.235400E-01 |
| AfricanAmerican-vs-Asian |
2.388800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.98289999975287E-07 |
| Normal-vs-Female |
1.059210E-01 |
| Male-vs-Female |
2.295400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.466200E-02 |
| Normal-vs-Extreme_Weight |
1.75290004733597E-09 |
| Normal-vs-Obese |
7.540400E-03 |
| Normal-vs-Extreme_Obese |
2.00299999999487E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.635220E-01 |
| Normal_Weight-vs-Obese |
8.841400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.121800E-02 |
| Extreme_Weight-vs-Obese |
1.286240E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.212000E-01 |
| Obese-vs-Extreme_Obese |
2.878800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.537000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.395600E-04 |
| Normal-vs-Age(61-80Yrs) |
2.46800000436309E-08 |
| Normal-vs-Age(81-100Yrs) |
1.13739999640927E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.878400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.291500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.839300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.659600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.848700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.071600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.01819663811398E-11 |
| Normal-VS-Type2 PRCC |
3.424500E-03 |
| Normal-VS-KIRP CIMP |
4.484200E-02 |
| Normal-VS-Unclassified PRCC |
5.536200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.769500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.622200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.346040E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.37300000000596E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.836600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.105630E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.182510E-04 |
| Normal-vs-N1 |
9.033000E-01 |
| Normal-vs-N2 |
6.619400E-01 |
| N0-vs-N1 |
5.777800E-02 |
| N0-vs-N2 |
7.349400E-01 |
| N1-vs-N2 |
6.422200E-01 |
|
|
